title: [Serine protease inhibitors in plasma of patients with ulcerative colitis].
abstract: Serine protease inhibitors (serpins) are the important factors regulating hemostasis and inflammatory mediators activity. The aim of this study was to determine relationships between plasma serine protease inhibitors activities and the course of ulcerative colitis (uc).
  
  
  METHODS
  42 patients with uc, 21 in active and 21 in inactive disease phase, and 26 healthy persons (control group) were studied. In all investigated persons activities of alpha 1-proteinase inhibitor (alpha 1-PI), alpha 2-macroglobulin (alpha 2-M), alpha 2-antiplasmin (alpha 2-AP), antithrombin III (ATIII) and plasminogen activator inhibitor type 1 (PAI-1) were determined.
  
  
  RESULTS
  Patients with uc had higher level of alpha 1-PI than control group. In patients with active uc lower alpha 2-M activity was found than in patients with us remission. Alpha 2-M activity below 100% had 58% sensitivity and 71% specificity, and predictive value (odds ratio = 6.25) for histologic appearance of active uc. The correlation between alpha 2-M value and uc activity and time of symptoms duration before the study start was found. Patients with inflammatory process beyond sigmoid had lower alpha 2-AP activity than patients with less extended inflammatory process.
  
  
  CONCLUSIONS
  Inflammatory process in large bowel changed the level of plasma serine protease inhibitors activities, what was a result of acute phase reaction (alpha 1-PI) and inhibitors consumption in inflammatory processes (alpha 2-M, alpha 2-AP).
authors.affiliation: Katedra i Klinika Gastroenterologii i Chorób Wewnetrznych Akademii Medycznej im. L. Rydygiera w Bydgoszczy.
authors.forename: M
authors.initials: M
authors.lastname: Swiatkowski
authors.forename: G
authors.initials: G
authors.lastname: Pulkowski
authors.forename: M
authors.initials: M
authors.lastname: Kłopocka
authors.forename: J
authors.initials: J
authors.lastname: Budzyński
authors.forename: E
authors.initials: E
authors.lastname: Wiśniewsk
authors.forename: M
authors.initials: M
authors.lastname: Kotschy
mesh_terms: D000210:Acute-Phase Reaction / Q000097:blood*; D000990:Antithrombin III / Q000032:analysis; D015415:Biomarkers / Q000097:blood; D003093:Colitis, Ulcerative / Q000097:blood* / Q000473:pathology; D018450:Disease Progression; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D017396:Plasminogen Activator Inhibitor 2 / Q000097:blood; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D015842:Serine Proteinase Inhibitors / Q000097:blood*; D000979:alpha-2-Antiplasmin / Q000032:analysis; D000511:alpha-Macroglobulins / Q000032:analysis
chemical_list: D015415:Biomarkers; D017395:Plasminogen Activator Inhibitor 1; D017396:Plasminogen Activator Inhibitor 2; D015842:Serine Proteinase Inhibitors; D000979:alpha-2-Antiplasmin; D000511:alpha-Macroglobulins; D000990:Antithrombin III